FIELD: veterinary medicine.
SUBSTANCE: method involves parenterally introducing anti-myxomatosis vaccine produced from B-82 strain or myxoma suspension in the amount of single immunizing dose four times with 24 h long pauses.
EFFECT: avoided or considerably reduced losses.
4 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT RABBITS WITH MYXOMATOSIS | 2017 |
|
RU2663324C1 |
VIRUS-VACCINE AGAINST MYXOMATOSIS OF RABBITS AND METHOD OF MANUFACTURING THE SAME | 1983 |
|
RU1169221C |
ASSOCIATED VACCINE AGAINST MYXOMATOSIS, PASTEURELLOSIS AND VIRAL HAEMORRHAGIC DISEASE 1 AND TYPE 2 OF RABBITS | 2020 |
|
RU2741643C1 |
METHOD FOR PREVENTING MYXOMATOSIS IN RABBITS | 2006 |
|
RU2317826C1 |
METHOD OF ANIMAL IMMUNIZATION | 0 |
|
SU1676629A1 |
METHOD FOR PREDICTING MYXOMATOSIS IN RABBITS | 2004 |
|
RU2279088C2 |
ATTENUATED STRAIN MIKS-98 (FAMILY POXVIRIDAE, GENUS LEPORIPOXVIRUS, MYXOMA VIRUS OF RABBITS) OF RABBIT MYXOMA VIRUS | 2001 |
|
RU2192465C1 |
MULTIPOTENT VACCINE FOR PREVENTION AND TREATMENT OF PRIMARILY INVASIVE AND INFECTIOUS DISEASES, METHOD OF USE | 2014 |
|
RU2583886C2 |
METHOD OF BREEDING YOUNG FARM ANIMALS | 0 |
|
SU1521432A1 |
METHOD FOR INCREASING PRODUCTIVITY IN CATTLE AND IMPROVING PRODUCTION QUALITY | 2002 |
|
RU2229827C2 |
Authors
Dates
2005-09-10—Published
2004-02-09—Filed